Nanomaterial for Treatment of Viral Immune Response

In recent decades, the world has witnessed the relentless emergence and re-emergence of viral infections, posing significant threats to global public health. From the devastating outbreaks of influenza, HIV, and Ebola to the more recent challenges posed by SARS-CoV-2, these viral pathogens have repeatedly exposed the vulnerabilities of our immune systems and the limitations of conventional therapeutic approaches. The ever -evolving nature of viruses demands innovative and adaptable solution to combat their pathogenicity and virulence. Nanotechnology, a cutting-edge interdisciplinary field, has emerged as a promising frontier in the battle against viral infections. Harnessing the unique properties and behaviors of nanomaterial's, researchers and clinicians have made substantial progress in developing novel strategies to treat viral immune responses progress in developing novel strategies to treat viral immune responses and mitigate the devastating effects of viral diseases. "Nanomaterials for treatment of Viral Immune Responses" offers an illuminating exploration of the innovative applications of nanotechnology in the ongoing battle against viral disease.

Autorentext

Mit einer Gesamterfahrung von über 16 Jahren in Forschung und Lehre ist Dr. Sayantan Mukhopadhyay derzeit als Professor und Direktor am College of Pharmacy in Dehradun tätig. Die Tatsache, dass er mehr als 50 Forschungs- und Übersichtsarbeiten veröffentlicht hat, mehrere Patente hält und Bücher und Buchkapitel verfasst hat, unterstreicht sein Fachwissen in diesem Bereich.